Prior to his role at BioAgilytix, Jeff was a scientific consultant for both biotechnology and major pharmaceutical companies in the requirements for successful regulatory submissions of bioanalytical data related to immunogenicity, biomarkers, PK/PD, biosimilarity, and bioassays and potency testing. He was also formerly Manager of Bioanalytical Chemistry for Trimeris, Inc., and was the RTP Site Head for GlaxoSmithKline’s Pharmacodynamic Exploratory Research Lab (PERL). Jeff has a B.S. in Chemistry from North Carolina State University and is a frequent, sought-after contributor for industry whitepapers and publications. Prior to his role at BioAgilytix, Jeff was a scientific consultant for both biotechnology and major pharmaceutical companies in the requirements for successful regulatory submissions of bioanalytical data related to immunogenicity, biomarkers, PK/PD, biosimilarity, and bioassays and potency testing. He was also formerly Manager of Bioanalytical Chemistry for Trimeris, Inc., and was the RTP Site Head for GlaxoSmithKline’s Pharmacodynamic Exploratory Research Lab (PERL). Jeff has a B.S. in Chemistry from North Carolina State University and is a frequent, sought-after contributor for industry whitepapers and publications.

Biopharmaceutical Science, Business Management